Pharmacological Characterization of a Novel ENaC[alpha] siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis
Lung pathology in cystic fibrosis is linked to dehydration of the airways epithelial surface which in part results from inappropriately raised sodium reabsorption through the epithelial sodium channel (ENaC). To identify a small-interfering RNA (siRNA) which selectively inhibits ENaC expression, che...
Gespeichert in:
Veröffentlicht in: | Molecular therapy. Nucleic acids 2013-01, Vol.2, p.e65 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!